Acorda Therapeutics, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 28.862 million compared to USD 28.099 million a year ago. Operating loss was USD 28.781 million compared to USD 6.169 million a year ago. Net loss was USD 33.451 million compared to USD 6.472 million a year ago. Basic loss per share from continuing operations was USD 3.53 compared to USD 0.81 a year ago.